Early passaging of mesenchymal stem cells does not instigate significant modifications in their immunological behavior

BACKGROUND: Bone marrow-derived allogeneic mesenchymal stem cells (MSCs) from young healthy donors are immunoprivileged and their clinical application for regenerative medicine is under evaluation. However, data from preclinical and initial clinical trials indicate that allogeneic MSCs after transpl...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Stem Cell Res Ther
Autori principali: Sareen, Niketa, Sequiera, Glen Lester, Chaudhary, Rakesh, Abu-El-Rub, Ejlal, Chowdhury, Subir Roy, Sharma, Vikram, Surendran, Arun, Moudgil, Meenal, Fernyhough, Paul, Ravandi, Amir, Dhingra, Sanjiv
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2018
Soggetti:
Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5930635/
https://ncbi.nlm.nih.gov/pubmed/29720263
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13287-018-0867-4
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi